Further molecular analysis showed that Sel‐GemPac treatment caused suppression of calcium/calmodulin‐dependent protein kinase 1 D (CAMK1D), long non‐coding RNA (lncRNA) GM42418 and MALAT1 in most of the clusters of treated KPC tumour cells (Figure 6B). The gene discussed is CAMK1D; the disease is neoplasm.